Giulia C. Kennedy, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 2 shares at $29.34 ($59) on 2022-11-11, disclosed to the SEC on 2022-11-15.
Scheduled sale ($59) by Chief Scientific & Med Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VCYT | SELL | 2022-08-09 | $27K | — | Filing → |
| VCYT | SELL | 2022-03-09 | $1.0M | — | Filing → |
| VCYT | SELL | 2022-03-07 | $425K | — | Filing → |